Allchem Lifescience Limited IPO

Allchem Lifescience Limited IPO

Bidding period

To be announced

Bid price

To be announced

Listing on

To be announced

Listing date

To be announced

Lot size

To be announced

Issue size

To be announced


Minimum investment

To be announced

Maximum investment

To be announced

Open Demat Account
Open Demat Account

Pre-issue Post-issue
Promoter group 0.0 0.0
Public group 100.0 100.0

Information currently unavailable

  • Long-standing relationships with a stable customer base.

  • Diversified customer base with strong export credentials.

  • Well established Manufacturing Facility with a focus on sustainability.

  • Strong focus on developing new chemistries leading to diverse products with a wide range of industrial applications.

  • Supply chain management in an industry with high entry barriers.

  • Experienced Promoters with domain knowledge.

  • Track record of consistent financial performance and growth.

  • The company business is significantly dependent on demand from the application industries, in particular pharmaceutical industry. Its derived 96.64%, 90.85%, 93.86% and 90.48% of the revenue from operations during the 6 months ended September 30, 2024, Fiscal 2024, Fiscal 2023 and Fiscal 2022, respectively, from the pharmaceutical industry. Any downturn in the application industries could have an adverse impact on the Company's business and results of operations.

  • Its business is significantly reliant on certain key customers, and the derived 59.37%, 54.09%, 50.31% and 62.44% of our revenue from operations during the 6 months ended September 30, 2024, Fiscal 2024, Fiscal 2023 and Fiscal 2022, respectively, from the top 10 customers. Further, its do not enter into any long term contracts with the customers. Loss of any of these customers or loss of revenue from sales to any key customers could have a material adverse effect on the business, financial condition, results of operations and cash flows.

  • The company source of revenue is concentrated to certain geographical locations. Further, its revenue from operations is also concentrated to certain regions in India. The company inability to operate and grow the business in such locations may have an adverse effect on the business, financial condition, result of operation, cash flow and future business prospects.

  • The company significantly reliant on a few vendors, and its do not enter into long-term contracts or arrangements with the vendors. Any loss of vendors will have a material adverse impact on the business and its revenue. Further, if the company is unable to procure raw materials of the required quality and quantity, at competitive prices, its business, results of operations and financial condition may be adversely affected.

  • Revenue from manufacturing API intermediates constitutes a significant majority of the revenue from operations and failure to maintain and augment its revenue therefrom could materially adversely affect the business and financial condition.

  • Failures to meet quality standards required by its customers may lead to cancellation of existing and future orders and expose it inter alia to warranty claims, including monetary liability, which may have an impact on the reputation, business and the financial condition.

  • Its dependent on third party logistic and support service providers for the delivery of raw materials and finished products and any disruptions in their services including transportation services or a decrease in the quality of their services may adversely affect of the business, financial condition and results of operations.

  • The Company has a high working capital requirement and if the Company is unable to raise sufficient working capital, the operations of the Company will be adversely affected.

  • Delays in payments from the customers exposes it to credit risk and it may have an adversely impact its results of operations and cash flows.

  • The company has incurred indebtedness which exposes us to various risks which may have an adverse effect on its business, results of operations and financial conditions. Conditions and restrictions imposed on it by the agreements governing its indebtedness could adversely affect the ability to operate the business.

MUFG Intime India Pvt Ltd

Phone number +91 8108114949
E-mail ID allchemlifescience.ipo@in.mpms.mufg.com
Website https://in.mpms.mufg.com

QIB shares offered

0 (0.0%)

NII (HNI) shares offered

0 (0.0%)

Retail shares offered

0 (0.0%)

Anchor investor shares offered

0 (0.0%)

Total shares offered

0

Total shares with anchor investor

0

  • Emkay Global Financial Services Ltd

Explore other IPOs

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)